Palais de l’Europe, Menton, France, October 4th-6th, 2018
Dear friends and colleagues,
We are pleased to announce the 7th international workshop on PET in lymphoma and myeloma (PILM), which will be held, as usual, in Menton in October 4th-6th, 2018. Now open to myeloma imaging since 2014, the meeting will dedicate a session to this topic as well as to the new criteria for PET in myeloma. The latter is a critical aspect of MM imaging to which some members of PILM scientific committee are currently dedicated. We will also devote an entire session to very interesting new tracers such as the radio-conjugate imaging CXCR4 and to their perspectives. Another session will address PET and minimal residual disease. Presentations of correlation between PET quantitative parameters and data obtained from molecular biology or liquid biopsy will be discussed as well as models relating PET metabolic tumor volume and tcDNA. A session will focus on the advances in volume and total lesion glycolysis and how it can be integrated within the prognostic indices. Moreover in 2018 the results from several important PET guided trials will be available and presented by the different cooperative groups. Another important new of the 2018 meeting edition will be the joint session with the international cancer imaging society (ICIS) whose annual meeting starts in that date. This joint session planned on October 7th morning will focus on Bone Marrow imaging in hematological malignancies. These and other innovative aspects of imaging (radiomics and radiomics associated to metabolomics) will contribute to maintain the high scientific level of the meeting, which used to be, along with the friendly and informal atmosphere of the scientific sessions the main characteristic of the previous workshop editions.